NFKB1 and Alzheimer disease: In addition, increased NF-κB and IL-1β in both APP/PS1 mouse brains and HT-22 cells were substantially reduced by LSZ treatment, suggesting the anti-inflammatory effects of LSZ also play an important role in its functions of anti-AD-like pathology.